Community-Acquired Pneumonia clinical trials
The registry lists 324 studies for Community-Acquired Pneumonia across more than 10 countries. 77 are recruiting or about to start. 259 of them are mainly about Community-Acquired Pneumonia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.
Get an email when these change. Save the Community-Acquired Pneumonia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Pfizer (13) · Capital Medical University (6) · Assistance Publique - Hôpitaux de Paris (6) · Assiut University (6) · Qingyuan Zhan (6) · Hellenic Institute for the Study of Sepsis (5) · UMC Utrecht (5) · Bayer (5)
What is being tested here
Drugs under test in Community-Acquired Pneumonia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Amoxicillin | 5 | 2 | 12 |
| Methylprednisolone | 5 | 4 | 8 |
| Azithromycin | 2 | 3 | 6 |
| Ceftriaxone | 2 | 0 | 5 |
| Interleukin 1 Receptor Antagonist Protein | 2 | 2 | 3 |
| Hydroxychloroquine | 2 | 3 | 3 |
| Tocilizumab | 2 | 2 | 2 |
| Aspirin | 2 | 2 | 2 |
| Baloxavir | 2 | 2 | 2 |
| Baricitinib | 2 | 2 | 2 |
Drug classes tested here Corticosteroids 6 open · Beta-lactamase inhibitors 2 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Targeting Vascular INflammation in Patients With Community-Acquired Pneumonia · Phase 3 · Ottawa Heart Institute Research Corporation
- May 2027Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia · Phase 3 · Assistance Publique - Hôpitaux de Paris
- May 2027Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward · Phase 3 · Nantes University Hospital
- Jun 2027Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia. · Phase 3 · St. Justine's Hospital
- Jun 2027Adaptive RCT of Corticosteroids for Severe Adenovirus Pneumonia in Adults · Phase 3 · Qingyuan Zhan
- Jun 2027Corticosteroids for PJP in Non-HIV Immunocompromised Adults · Phase 3 · Qingyuan Zhan
- Nov 2026Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia · Assiut University
- Nov 2026A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia · Pfizer
- Nov 2026ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly Patients · Joan Sabater-Riera
- Dec 2026Clinical Impact of Rapid Molecular Testing for Pathogens in Patients With Severe Acute Respiratory Illness : A Pragmatic Trial · National Taiwan University Clinical Trial Center
Who these studies take
Of the 41 Community-Acquired Pneumonia studies recruiting now, 29 (71%) set no upper age limit and 9 (22%) stop at 75 or younger. 13 (32%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (12%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 11 (27%) | 11 (27%) |
| 18 | 36 (88%) | 36 (88%) |
| 30 | 30 (73%) | 30 (73%) |
| 40 | 30 (73%) | 30 (73%) |
| 50 | 30 (73%) | 30 (73%) |
| 65 | 33 (80%) | 33 (80%) |
| 75 | 32 (78%) | 32 (78%) |
| 85 | 32 (78%) | 32 (78%) |
Across all 324 studies, recruiting or not: 23% stop at 75 or younger and 19% at 65; 25% take children; 0% are for women only and 0% for men only; 6% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Community-Acquired Pneumonia studies take
Of 43 interventional studies with no phase under Community-Acquired Pneumonia, half reached primary completion within 24 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 24 mo14–38 · 43 studies | — | 24 mo15–38 · 42 studies |
| Observational | 31 mo22–57 · 38 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Stopped1
- Community-Acquired Pneumonia Diagnosis Using Lung Ultrasound in Emergency Room AdultsTerminatedNov 4, 2026NCT04210102
Newly registered2
Studies
Recruiting first, then most recently updated. Showing 50 of 324. Browse all 324 → or search them.
- Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.RecruitingNCT066019981 country
- Ceftriaxone Dosage for Non-Critical Community-Acquired PneumoniaNot yet recruitingNCT07537413Phase 41 country
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingNCT02735707Phase 329 countries
- CLARITHROMYCIN TO PREVENT SECONDARY INFECTIONS IN PATIENTS WITH SEPSIS FOLLOWING LOWER RESPIRATORY TRACT INFECTIONS: THE CLASSIFY TRIALRecruitingNCT07834346Phase 31 country
- Multimodal Stewardship Programme to Improve Antibiotic Prescribing for Children With Lower Respiratory Tract InfectionsNot yet recruitingNCT07893834Not applicable1 country
- Traditional Chinese Medicine in Multidrug-Resistant Bacterial PneumoniaNot yet recruitingNCT077260951 country
- Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Novel DiagnosticsRecruitingNCT06114888Not applicable1 country
- Chest Radiography Versus Ultra-Low-Dose Chest Computed Tomography in Adults in the Emergency DepartmentRecruitingNCT078705251 country
- AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired PneumoniaRecruitingNCT05848713Phase 34 countries
- Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactamsRecruitingNCT07164131Phase 41 country
- Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired PneumoniaRecruitingNCT06996834Not applicable1 country
- Antibiotic Prescription in Children Hospitalized for Community-acquired PneumoniaRecruitingNCT046813391 country
- Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)RecruitingNCT05722938Phase 318 countries
- TCM Cohort for Elderly CAPNot yet recruitingNCT077976861 country
- Lefamulin Post-Market Surveillance StudyRecruitingNCT076978851 country
- Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 YearsRecruitingNCT060299331 country
- Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BALRecruitingNCT06134492Phase 31 country
- Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor ScoreRecruitingNCT076815831 country
- Community-acquired Pneumonia Due to Chlamydia PneumoniaeNot yet recruitingNCT076797891 country
- 3 vs. 5 Days of Amoxicillin for Childhood Pneumonia: An RCTNot yet recruitingNCT07647835Early Phase 11 country
- Multimodal Assisted Diagnosis for Pediatric Respiratory Diseases Using Questionnaires, Cough Sounds, and Breath SoundsNot yet recruitingNCT076132421 country
- ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly PatientsEnrolling by invitationNCT070702846 countries
- Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in PneumoniaNot yet recruitingNCT07583992Phase 21 country
- Targeting Vascular INflammation in Patients With Community-Acquired PneumoniaRecruitingNCT06710080Phase 31 country
- A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC StudyRecruitingNCT06325293Not applicable1 country
- Epidemiological Study on Community Acquired PneumoniaRecruitingNCT021391631 country
- Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow TherapyRecruitingNCT06966310Not applicable1 country
- PromotIng Optimal Treatment for Community-acquired PNeumonia in EmErgency RoomsRecruitingNCT07099976Not applicable1 country
- Randomised Evaluation of COVID-19 TherapyRecruitingNCT04381936Phase 316 countries
- Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit WardRecruitingNCT06229288Phase 31 country
- Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)RecruitingNCT06892197Phase 41 country
- Effect of tNGS on CAP Patients With Initial Treatment FailureNot yet recruitingNCT07472114Not applicable1 country
- Frailty and Outcomes in Older Emergency Department Patients With PneumoniaRecruitingNCT074426561 country
- Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAPRecruitingNCT06494072Phase 41 country
- Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)RecruitingNCT06986148Not applicable1 country
- Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired PneumoniaNot yet recruitingNCT07357935Phase 1/2
- Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary CareRecruitingNCT07359287Not applicable1 country
- Adaptive RCT of Corticosteroids for Severe Adenovirus Pneumonia in AdultsNot yet recruitingNCT07152600Phase 3
- Adaptive RCT of Corticosteroids for Severe Influenza Pneumonia in AdultsNot yet recruitingNCT07351500Phase 3
- Adaptive RCT of Corticosteroids for Severe Chlamydia Psittaci Pneumonia in AdultsNot yet recruitingNCT07352865Phase 3
- Epidemiology and Current Practices in Severe Community-Acquired PneumoniaNot yet recruitingNCT073010991 country
- Coenzyme Q10 in Pediatric Community-Acquired PneumoniaNot yet recruitingNCT07317440Not applicable1 country
- Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent AsthmaNot yet recruitingNCT07315555Not applicable
- Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)RecruitingNCT06294600Phase 31 country
- The Fever Clinic Acute Respiratory CohortRecruitingNCT072787001 country
- Clinical Predictors of Severity in Pediatric Community-Acquired Pneumonia at Assiut University Children's HospitalNot yet recruitingNCT07279675
- Physical Rehabilitation of Older Persons Following a Community-Acquired Infection Hospitalization - A Randomised-Controlled TrialNot yet recruitingNCT06689280Not applicable1 country
- ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT)RecruitingNCT067558141 country
- OPT101 in Patients With Community Acquired Pneumonia (CAP) With SepsisNot yet recruitingNCT06669403Phase 11 country
- Corticosteroids for PJP in Non-HIV Immunocompromised AdultsNot yet recruitingNCT07152613Phase 3